Nitric oxide - Cyclic GMP pathway regulates vascular smooth muscle cell phenotypic modulation: Implications in vascular diseases

Acta Physiologica Scandinavica

Volumn 164, Issue 4, 1998, Pages 507-515

  Lincoln, Thomas M ^a   Dey, N B ^a   Boerth, N J ^a   Cornwell, T L ^a   Soff, G A ^b  

^a University of Alabama at Birmingham   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Contractile; Cyclic nucleotides; Extracellular matrix; Protein kinase

Indexed keywords

ALPHA ACTIN; CALPONIN; COMPLEMENTARY DNA; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE; FIBROBLAST GROWTH FACTOR RECEPTOR; MYOSIN HEAVY CHAIN; NITRIC OXIDE; NITRIC OXIDE DONOR; OSTEOPONTIN; THROMBOSPONDIN;

ANIMAL CELL; AORTA; BLOOD VESSEL INJURY; CATTLE; CELL CULTURE; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVE SITE; GENETIC TRANSFECTION; INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0032427671     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.1998.tb10700.x     Document Type: Conference Paper

References (45)

1. Alberts, G.F., Hsu, D.K.W., Peifley, K.A. & Winkles, J.A. 1994. Differential regulation of acidic and basic fibroblast growth factor gene expression in fibroblast growth factor-treated rat aortic smooth muscle cells. Circ Res 75, 261-267.
2. Barja, F., Cougglin, C., Belin, D. & Gabbiani, G. 1986. Actin isoform synthesis and mRNA levels in quiescent and proliferating rat aortic smooth muscle cells in vivo and in vitro. Lab Invest 64, 5-15.
3. Boerth, N.J., Dey, N., Cornwell, T.L. & Lincoln, T. M. 1997. cGMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res 34, 245-259.
4. Bolotina, V.M., Najibi, S., Palacino, J.J. & Cohen, R.A. 1994. Nitric oxide directly activates calcium-activated potassium channels in vascular smooth muscle. Nature 368, 850-853.
5. Campbell, J.H. & Campbell, G.R. 1985. Smooth muscle cell phenotype changes in arterial wall homeostasis: implication for the pathogenesis of atherosclerosis. Exp Molec Pathol 42, 136-162.
6. Cao, M., Westerhausen-Larson, A., Niyibixi, C., Kavalkovich, K. et al. 1997. Nitric oxide inhibits the synthesis of type II collagen without altering Col2A1 mRNA abundance: prolylhydroxylase as a possible target. Biochem J 324, 305-310.
7. Casscells, W., Lappi, D.A., Olwin, B.B. et al. 1992. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci USA 89, 7159-7163.
8. Cayatte, A.J., Palacino, J.J., Horten, K. & Cohen, R.A. 1994. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14, 753-759.
9. Chamley-Campbell, J., Campbell, G.R. & Ross, R. 1979. The smooth muscle cell in culture. Physiol Rev 59, 1-61.
10. Chamley-Campbell, J., Campbell, G.R. & Ross, R. 1981. Phenotype-dependent response of cultured aortic smooth muscle cells to serum mitogens. J Cell Biol 89, 379-383.
11. Cornwell, T.L., Arnold, E., Boerth, N.J. & Lincoln, T.M. 1994a. Inhibition of smooth muscle cell proliferation by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 36, C1405-C1413.
12. Cornwell, T.L., Soff, G.A., Traynor, A.E. & Lincoln, T.M. 1994b. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res 31, 330-337.
13. Dey, N.B., Boerth, N.J., Murphy-Ullrich, J.E., Chang, P.L., Prince, C.W. & Lincoln, T.M. 1998. Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ Res 82, 139-146.
14. Dubey, R.K., Jackson, E.K. & Luscher, T.F. 1995. Nitric oxide inhibits angiotensin II-mediated migration of rat aortic smooth muscle cells. J Clin Invest 96, 141-149.
15. Frid, M.G., Printesva, O.Y., Chiavegato, A. et al. 1993. Myosin heavy chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res 30, 279-292.
16. Garg, U.C. & Hassid, A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83, 1774-1777.
17. Gimona, M., Hersog, M., Vandederckhove, J. & Small, J.V. 1990. Smooth muscle specific expression of calponin. FEBS Lett 274, 159-162.
18. Glukhova, M.A., Frid, G. & Koteliansky, V.E. 1990. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J Biol Chem 265, 13042-13046.
19. Gown, A.M., Tsukada, T. & Ross, R. 1986. Human atherosclerosis II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 125, 191-207.
20. Harder, D.R., Lange, A.R., Gebremedhin, D., Birks, E.K. & Roman, R.J. 1997. Cytochrome p450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 34, 237-243.
21. Hedin, U., Sjolund, M., Hultgardh-Nilsson, A. & Thyberg, J. 1990. Changes in expression and organization of smooth muscle-specific α-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. Differentiation 44, 222-231.
22. Hofmann, F., Dostmann, W., Keilbach, A. & Landgraff, W. 1992. Structure and physiological role of cGMP-dependent protein kinase. Biochim Biophys Acta 1135, 51-60.
23. Hughes, S.E. 1996. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Cardiovasc Res 32, 557-569.
24. Ignarro, L.J. & Kadowitz, P. 1985. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann Rev Pharmacol Toxicol 25, 171-191.
25. Kariya, K., Kawahara, Y., Araki, S., Fukuzaki, H. & Takai, Y. 1989. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis 80, 143-147.
26. Kawamoto, S. & Adelstein, R.S. 1987. Characterization of myosin heavy chains in cultured aorta smooth muscle cells: a comparative study. J Biol Chem 262, 7282-7288.
27. Kuro-o, M., Nagai, R., Nakahara, K. et al. 1991. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 266, 3768-3773.
28. Kuro-o, M., Nagai, R., Tsuchimochi, H. et al. 1989. Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 264, 18272-18275.
29. Lincoln, T.M. & Cornwell, T.L. 1993. Intracellular cyclic GMP receptor proteins. FASEB J 7, 328-338.
30. Lincoln, T.M., Cornwell, T.L., Komalavilas, P., MacMillan-Crow, L.A. & Boerth, N.J. 1996. The Nitric Oxide-Cyclic GMP Signaling System. In: M. Barany (ed) Biochemistry of Smooth Muscle Contraction, pp. 257-268. Academic Press, San Diego, CA.
31. Majesky, M.W., Giachelli, C.M., Reidy, M.A. & Schwartz, S. M. 1992. Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated phenotype during repair of arterial injury. Circ Res 71, 759-768.
32. McNamara, D.B., Bedi, B., Aurora, H., Tena, L., Ignarro, L.J., Kadowitz, P.J. & Akers, D.L. 1993. 1-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 193, 291-296.
33. Moro, M.A., Russell, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W. & Moncada, S. 1996. cGMP mediates the vascular and platelet action of nitric oxide: confirmation using an inhibitor of soluble guanylyl cyclase. Proc Natl Acad Sci USA 93, 1480-1485.
34. Mosse, P.R., Campbell, G.R., Wang, Z.L. & Campbell, J.H. 1985. Smooth muscle phenotypic expression in human carotid arteries I.Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 53, 556-562.
35. Nabel, E.G., Yang, Z.-Y., Plautz, G. et al. 1993. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362, 844-846.
36. Nakaki, T., Nakayama, M. & Kato, R. 1990. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 189, 347-353.
37. Periasamy, M. & Nagai, R. 1995. Molecular basis of smooth muscle contractility - myosin heavy chains: gene structure and expression. In: S.M. Schwartz & R.P. Mecham (eds) The Vascular Smooth Muscle Cell, pp. 189-211. Academic Press, San Diego, CA.
38. Rizvi, M.A. & Myers, P.R. 1997. Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J Mol Cell Cardiol 29, 1779-1789.
39. Rovner, A.S., Murphy, R.A. & Owens, G.K. 1986. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem 261, 14740-14745.
40. Sarkar, R., Meinberg, E.G., Stanley, J.C., Gordon, D. & Webb, R.C. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 78, 225-230.
41. Sartore, S., Scatena, M., Chiavegato, A., Faggin, E., Giuriato, L. & Pauletto, P. 1994. Myosin isoform expression in smooth muscle cells during physiological and pathological vascular remodeling. J Vasc Res 31, 61-81.
42. Shanahan, C.M., Weissberg, P.C. & Metcalfe, J.C. 1993. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 73, 193-204.
43. Soff, G., Cornwell, T.M., Cundiff, D.L., Gately, S. & Lincoln, T.M. 1997. Smooth muscle cell expression of type I cyclic GMP-depenclent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. J Clin Invest 100, 2580-2587.
44. Trachtman, H., Futterweit, S. & Singhal, P. 1995. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochern Biophys Res Commun 207, 120-125.
45. Ueki, N., Sobue, K., Kanda, K., Hada, T. & Higashino, K. 1987. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 84, 9049-9053.